Adjuvant Use of Pembrolizumab for Stage III Melanoma in a Real-World Setting in Europe.

Autor: Weichenthal, Michael1 (AUTHOR) mweichenthal@dermatology.uni-kiel.de, Mangana, Joanna2 (AUTHOR) johanna.mangana@usz.ch, Gavrilova, Iva3 (AUTHOR) ivaga81@yahoo.com, Lugowska, Iwona4 (AUTHOR) iwona.lugowska@pib-nio.pl, Shalamanova, Gergana Krumova5 (AUTHOR) gery_dd@abv.bg, Kandolf, Lidija6 (AUTHOR) lkandolfsekulovic@gmail.com, Chiarion-Sileni, Vanna7 (AUTHOR) vanna.chiarion1@gmail.com, Mohr, Peter8 (AUTHOR) peter.mohr@elbekliniken.de, Karanikolova, Teodora Sotirova9 (AUTHOR) teddy.karanikolova@abv.bg, Teterycz, Pawel4 (AUTHOR) pawel.teterycz@pib-nio.pl, Espinosa, Enrique10 (AUTHOR) e.espinosa@salud.madrid.org, Schnecko, Philipp11 (AUTHOR), Cheng, Phil2 (AUTHOR) phil.cheng@usz.ch, Bender, Marc12 (AUTHOR) marc.bender@elbekliniken.de, Jiang, Shan13 (AUTHOR) shan.jiang1@merck.com, Burke, Thomas13 (AUTHOR) thomas_burke2@merck.com, Ascierto, Paolo Antonio14 (AUTHOR) paolo.ascierto@gmail.com, Gogas, Helen15 (AUTHOR) helgogas@gmail.com, Rodas, Ivan Marquez16 (AUTHOR) ivanpantic@hotmail.com, Rutkowski, Piotr4 (AUTHOR) piotr.rutkowski@pib-nio.pl
Zdroj: Cancers. Nov2024, Vol. 16 Issue 21, p3558. 13p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje